Enhanced Secretion of Biologically Active Murine Interleukin-12 by Lactococcus lactis

被引：20
|
作者：
Fernandez, Antonio [1 ]
Horn, Nikki [1 ]
Wegmann, Udo [1 ]
Nicoletti, Claudio [1 ]
Gasson, Michael J. [1 ]
Narbad, Arjan [1 ]
机构：
[1] BBSRC Inst Food Res, Norwich NR4 7UA, Norfolk, England
来源：
APPLIED AND ENVIRONMENTAL MICROBIOLOGY | 2009年 / 75卷 / 03期
关键词：
CONTROLLED EXPRESSION; NISIN; STRAINS; SIGNAL; CYTOKINE; ANTIGEN; GENES; MICE;
D O I：
10.1128/AEM.01728-08
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The novel signal peptide SLPmod was used for the secretion of murine interleukin-12 (mIL-12) by Lactococcus lactis. A >4-fold increase in secretion was observed when SLPmod was used instead of the Usp45-derived secretion signal. Oral delivery of this cytokine using the autoinducible host L. lactis FI5876 utilizing SLPmod resulted in a significant increase in mIL-12 plasma levels in mice.
引用
收藏
页码：869 / 871
页数：3
相关论文
共 32 条
  • [21] Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells
    Rubinstein, Mark P.
    Su, Ee Wern
    Suriano, Samantha
    Cloud, Colleen A.
    Andrijauskaite, Kristina
    Kesarwani, Pravin
    Schwartz, Kristina M.
    Williams, Katelyn M.
    Johnson, C. Bryce
    Li, Mingli
    Scurti, Gina M.
    Salem, Mohamed L.
    Paulos, Chrystal M.
    Garrett-Mayer, Elizabeth
    Mehrotra, Shikhar
    Cole, David J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (05) : 539 - 549
  • [22] Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: Dose dependent tumor eradication and generation of protective immunity
    O'Donnell, MA
    Luo, Y
    Hunter, SE
    Chen, XH
    Hayes, LL
    Clinton, SK
    JOURNAL OF UROLOGY, 2004, 171 (03) : 1330 - 1335
  • [23] Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-α in a murine melanoma model
    Zagozdzon, R
    Stoklosa, T
    Golab, J
    Giermasz, A
    Dabrowska, A
    Lasek, W
    Jakóbisiak, M
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4493 - 4498
  • [24] Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF
    Aruga, E
    Aruga, A
    Arca, MJ
    Lee, WMF
    Yang, NS
    Smith, JW
    Chang, AE
    CANCER GENE THERAPY, 1997, 4 (03) : 157 - 166
  • [25] Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats
    Okura, Y
    Takeda, K
    Honda, S
    Hanawa, H
    Watanabe, H
    Kodama, M
    Izumi, T
    Aizawa, Y
    Seki, S
    Abo, T
    CIRCULATION RESEARCH, 1998, 82 (10) : 1035 - 1042
  • [26] Production of biologically active chicken interleukin (IL)-12 and IL-18 synthesized by the recombinant fowlpox virus
    Su, Bor Sheu
    Yin, Hsien Sheng
    Shien, Jui Hung
    Chiu, Hua Hsien
    Lee, Long Huw
    PROCESS BIOCHEMISTRY, 2010, 45 (07) : 1057 - 1064
  • [27] Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas
    Tevz, Gregor
    Kranjc, Simona
    Cemazar, Maja
    Kamensek, Urska
    Coer, Andrej
    Krzan, Mojca
    Vidic, Suzana
    Pavlin, Darja
    Sersa, Gregor
    JOURNAL OF GENE MEDICINE, 2009, 11 (12) : 1125 - 1137
  • [28] Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli 0157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB
    Ahmed, B.
    Loos, M.
    Vanrompay, D.
    Cox, E.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2013, 152 (1-2) : 141 - 145
  • [29] A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease
    Burakoff, Robert
    Barish, Charles F.
    Riff, Dennis
    Pruitt, Ronald
    Chey, William Y.
    Farraye, Francis A.
    Shafran, Ira
    Katz, Seymour
    Krone, Charles L.
    Vander Vliet, Martha
    Stevens, Christopher
    Sherman, Matthew L.
    Jacobson, Eric
    Bleday, Ronald
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (07) : 558 - 565
  • [30] Nucleic acids of Enterococcus faecalis strain EC-12 are potent Toll-like receptor 7 and 9 ligands inducing interleukin-12 production from murine splenocytes and murine macrophage cell line J774.1
    Inoue, Ryo
    Nagino, Takayuki
    Hoshino, Go
    Ushida, Kazunari
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2011, 61 (01): : 94 - 102
1234